Long COVID common in U.S. adults with prior COVID-19 infection
Some people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as post-COVID conditions (PCC)...
COVID vaccines don’t just benefit physical health – they improve mental health too
The considerable physical health benefits of COVID vaccines, in particular, the significantly reduced risk of serious illness, hospitalisation and death from the virus, are...
Yale designs new nasal vaccine to fight COVID-19
Intramuscular vaccine shots, which are what most people have received to protect against COVID-19 infection, provide a broad-based immune response throughout the body and...
New evidence on rare blood clots after COVID-19 vaccination
Scientists found new evidence on the risk of developing this very rare blood-clotting condition after COVID-19 vaccination.
COVID-19 virus is becoming less severe, study finds
In a study from Massachusetts General Hospital, scientists examined the severity of the SARS-CoV-2 omicron BA.2 subvariant (the strain making a re-emergence this fall).
They...
Common cholesterol-lowering drug may lower COVID-19 severity, death risk
Statin drugs lower low-density lipoprotein (LDL) cholesterol by slowing down the liver’s production of cholesterol.
They also increase the liver’s ability to remove LDL cholesterol...
Four ways to support a friend or loved one with long COVID
An estimated 2.3 million people in the UK are currently living with long COVID. The condition is most commonly reported by people aged 35-69, but it can affect people of any age.
What is – and what isn’t – ‘brain fog’?
The COVID pandemic has introduced many scientific and medical terms into our everyday language.
Many of us are now fluent in conversations about viral strains,...
COVID-19 linked to higher risk of heart disease and death
In a new study, scientists found COVID-19 infection is linked to a subsequent heightened risk of poor cardiovascular health and death, particularly among those...
Scientists find inexpensive, readily available drug that may treat COVID-19
In a study from the University of California, Los Angeles, scientists found that an inexpensive, readily available amino acid might limit the effects of...